Journal of Dermatological Science
Volume 42, Issue 1 , Pages 13-21, April 2006

Anti-inflammatory activity in skin by biomimetic of Evodia rutaecarpa extract from traditional Chinese medicine

  • Daniel B. Yarosh

      Affiliations

    • AGI Dermatics, 205 Buffalo Avenue, Freeport, NY 11520, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 516 868 9026; fax: +1 516 868 9143.
  • ,
  • Jason W. Galvin

      Affiliations

    • Department of Molecular & Cellular Biology, Stony Brook University, Stony Brook, NY 11794, United States
  • ,
  • Stephanie L. Nay

      Affiliations

    • AGI Dermatics, 205 Buffalo Avenue, Freeport, NY 11520, United States
  • ,
  • Arely V. Peña

      Affiliations

    • AGI Dermatics, 205 Buffalo Avenue, Freeport, NY 11520, United States
  • ,
  • Matthew T. Canning

      Affiliations

    • AGI Dermatics, 205 Buffalo Avenue, Freeport, NY 11520, United States
  • ,
  • David A. Brown

      Affiliations

    • AGI Dermatics, 205 Buffalo Avenue, Freeport, NY 11520, United States

Received 3 August 2005; received in revised form 15 November 2005; accepted 15 December 2005.

Summary 

Background

Wu-Zhu-Yu, is an extract prepared from the small berry fruit of Evodia rutaecarpa and is reported to have anti-inflammatory and anti-nociceptic activity. Methyl nicotinate (MN) is known to induce the release of PGD2 resulting in localized erythema within 30min after topical application to human skin.

Objective

The purpose of this study was to determine if a defined biomimetic mixture of components of Evodia fruit extract inhibit inflammation in human cells and skin.

Methods

In order to control the potency of the test article, we prepared a defined biomimetic mixture of synthetic and natural forms of the active components of Evodia fruit extract, containing rutaecarpine, dehydroevodiamine, and evodin. This was tested for anti-inflammatory activity in UVB-irradiated cultured cells and in the MN model of micro-inflammation in human skin.

Results

This Evodia biomimetic mixture was a potent inhibitor of UVB-induced PGE2 released by keratinocytes in culture. We found that MN also induces release of nitric oxide from cultured keratinocytes and microvascular endothelial cells. Twice daily application of 0.1–1% Evodia biomimetic mixture for 2 weeks significantly inhibited erythema after a MN challenge. A single application of 1% Evodia biomimetic mixture also significantly inhibited MN-induced erythema when applied at 60min before, or within 5min after MN exposure. The Evodia biomimetic mixture was significantly more effective at inhibiting erythema than bisabolol, the active component of chamomile.

Conclusions

These results demonstrate that compounds found in E. rutaecarpa (including the indole quinazoline alkaloids) have powerful anti-inflammatory activity when applied topically to human skin.

Abbreviations: BHT, butylated hydroxytoluene, COX-2, cyclooxygenase-2, HMVEC, human microvascular endothelial cells, MN, methyl nicotinate, NHEK, normal human epidermal keratinocytes, NO, nitric oxide, PGD2, prostaglandin D2, PGE2, prostaglandin E2, UVB, ultraviolet B

Keywords: Evodia rutaecarpa, Biomimetic, Methyl nicotinate, Prostaglandin, Nitric oxide, Inflammation, Skin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0923-1811(05)00348-8

doi:10.1016/j.jdermsci.2005.12.009

Journal of Dermatological Science
Volume 42, Issue 1 , Pages 13-21, April 2006